Skip to main content
  • Home
  • TAVI Haemodynamics and Outcomes: Are We Measuring Appropriately?

TAVI Haemodynamics and Outcomes: Are We Measuring Appropriately?

Topic:
  • Intervention
  • Structural Heart Disease

Available Credit:

  • 1.00 EBAC

Course Published On:

Course Expiry Date:

Overview

Join leading faculty to evaluate the relationship between TAVI and clinical outcomes based on clinical data whilst also summarising how haemodynamic monitoring can be adopted post-TAVI. This satellite symposium was part of Transcatheter Interventions Online 2021, a world-class virtual event dedicated to transcatheter treatment strategies for coronary and structural heart disease.

Disclosure

In compliance with EBAC / EACCME guidelines, all speakers/chairpersons participating in this programme have disclosed or indicated potential conflicts of interest which might cause a bias in the presentations.

 

The Organising Committee/Course Director is responsible for ensuring that all potential conflicts of interest relevant to the event are declared to the audience prior to the CME activities.

 

This programme is supported by unrestricted educational grants from Edwards Lifesciences. The scientific programme has not been influenced in any way by the sponsors.

Terms & Conditions

Radcliffe Education requires contributors to our CME programmes to disclose any relevant financial relationships that have occurred within the past 12 months that could create a conflict of interest. These will be identified in the faculty section if applicable.

 

The session of ‘TAVI Haemodynamics and Outcomes: Are We Measuring Appropriately ’ is accredited by the European Board for Accreditation in Cardiology (EBAC) for 1 hour of external CME credits.

 

Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).

 

Through an agreement between the European Board for Accreditation in Cardiology and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website.

Instructions to Participants

There is no fee for taking part in this online learning activity.

 

Activities are designed to be completed within 60 minutes and must be completed by the registered user. Physicians should only claim credits for time spent on the activity. To successfully earn credit, participants must complete the activity in full in the indicated time frame.

 

To complete the course and claim certification participants must:

  • Read the course outline information supplied and complete pre-test questions if supplied prior to starting the activity. Users must read and study the activity in its entirety before completing the post-test questions.
  • Your results will be automatically saved and if a pass score is achieved (where applicable), you may be eligible to claim credit for the activity and receive a certificate of completion.

Target Audience

This programme is intended to educate:

  • Electrophysiologists
  • Arrhythmologists
  • General cardiologists
  • Cardiac catheterization technologists and technicians
  • Physiologists
  • Device Implanting Specialist

Learning Objectives

The symposium, ‘TAVI Haemodynamics and Outcomes: Are We Measuring Appropriately?’, endeavours to best address the following learning objectives:

  • Describe how echo-based and catheter-based measurements differ when measuring haemodynamics post-TAVI
  • Recall common factors impacting the accuracy of haemodynamic measurements and how they can be controlled
  • Evaluate the relationship between TAVI and clinical outcomes based on clinical data
  • Summarise how haemodynamic monitoring can be adopted post-TAVI
Register now Log in

Module

Title

Duration

Speakers

1 Introduction Philippe Genereux (New Jersey, US)
2 Echo vs catheter-based measurements post-TAVI Philippe Pibarot (Quebec, Canada)
3 TAVI haemodynamics and clinical outcomes Philip MacCarthy (London UK)
4 Optimising haemodynamic monitoring post-TAVI David Wood (Vancouver, Canada)
5 Q&A and Discussion Philippe Genereux (New Jersey, US) Philippe Pibarot (Quebec, Canada) Philip MacCarthy (London UK) David Wood (Vancouver, Canada)
6 Summary Philippe Genereux (New Jersey, US)
1.

Introduction

Duration:

Speakers: Philippe Genereux (New Jersey, US)

2.

Echo vs catheter-based measurements post-TAVI

Duration:

Speakers: Philippe Pibarot (Quebec, Canada)

3.

TAVI haemodynamics and clinical outcomes

Duration:

Speakers: Philip MacCarthy (London UK)

4.

Optimising haemodynamic monitoring post-TAVI

Duration:

Speakers: David Wood (Vancouver, Canada)

6.

Summary

Duration:

Speakers: Philippe Genereux (New Jersey, US)

Chair

Philippe Genereux

Morristown Medical Center, NJ

Philippe Genereux is an interventional cardiologist at Morristown Medical Center, NJ.

View full profile

Panelist

Philippe Pibarot

Quebec Heart and Lung Institute, Laval University, Quebec, Canada

Philippe Pibarot is Full Professor at the Department of Medicine of Laval University, Canada.

View full profile

Philip MacCarthy

School of Cardiovascular Medicine & Sciences, BHF Centre of Excellence, King’s College London, UK

View full profile

David Wood

Vancouver General Hospital

Dr David Wood works as an interventional cardiologist at Vancouver General Hospital.

Dr Wood is a professor in the Department of Medicine at the University of British Columbia and a co-founding member of the Centre for Heart Valve Innovation in Vancouver.

View full profile

AVAILABLE CREDIT

1.00 European Board for Accreditation in Cardiology (EBAC)

Related Courses

Severe Aortic Stenosis: Stratifying Patients for Lifetime Management
  • 1 EBAC

Learning objectives

  • Describe the challenges with lifetime management in severe AS in both a SAVR and TAVI-first scenario
  • Summarise clinical evidence for TAVI in low surgical risk patients
  • Recall different guideline recommendations for SAVR and TAVI approaches
  • Assimilate current clinical knowledge with patient preferences when formulating treatment plans for severe AS patient
See more
Renal Denervation In The Real World: Practical Guidance For New Users
  • 1 EBAC

Learning objectives

  • Assess the current global burden of resistant hypertension
  • Carry out appropriate assessments to identify resistant hypertension
  • Identify patients most likely to benefit from RDN
  • Recall the practical considerations for adopting RDN into routine practice
  • Recall the latest data on RDN from recent clinical trials
See more
Getting it Right First Time in Severe Aortic Stenosis - Key insights for Long Term Success
  • 1 EBAC

Learning objectives

  • Recall current and predicted trends in TAVI with respect to preserving coronary access
  • Consider determining factors for choosing valves in low risk populations
  • Discuss solutions for maximising valve durability and haemodynamics and for treating degenerated TAVI
See more
Optimising Outcomes For The Tavi Patient: Key Considerations For First Valve Choice And Implantation Techniques

Learning objectives

  • Recall the latest data showing why durability and hemodynamics matter for initial valve selection
  • Discuss the latest techniques to help achieve optimal outcomes for patients with longer life expectancy
  • Review TAVI cases that highlight procedure optimisation with the Evolut pro+ platform
See more
Transcatheter Interventions Online - Session 3.4: Debates
  • 1 EBAC

Learning objectives

  • Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
  • Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
  • Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
  • Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
  • Discuss the need for gender-specific trials and renal denervation
See more
Transcatheter Interventions Online - Session 3.3: Keynote & Controversies: Live Cases And Discussion
  • 1 EBAC

Learning objectives

  • Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
  • Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
  • Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
  • Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
  • Discuss the need for gender-specific trials and renal denervation
See more
Transcatheter Interventions Online - Session 3.1 & 3.2: Keynote & Controversies
  • 1 EBAC

Learning objectives

  • Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
  • Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
  • Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
  • Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
  • Discuss the need for gender-specific trials and renal denervation
See more
Transcatheter Interventions Online - Session 2.4 Practical Pearls Toward a More Advanced CTO Programme: Live Cases and Discussion
  • 1 EBAC

Learning objectives

  • Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
  • Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
  • Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
  • Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
  • Discuss the need for gender-specific trials and renal denervation
See more
Transcatheter Interventions Online - Session 2.3: Practical Pearls Toward a More Advanced CTO Programme
  • 1 EBAC

Learning objectives

  • Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
  • Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
  • Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
  • Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
  • Discuss the need for gender-specific trials and renal denervation
See more
Transcatheter Interventions Online - Session 2.2: Strategies For Calcified Coronary Lesions Anno 2022: Live Cases And Discussion
  • 1 EBAC

Learning objectives

  • Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
  • Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
  • Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
  • Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
  • Discuss the need for gender-specific trials and renal denervation
See more